October 26, 2022

The American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO) today released a joint policy statement outlining the latest research on the use of e-cigarettes and other electronic nicotine delivery systems (ENDS) and recommendations for regulating these products to protect public health. The statement was published in the AACR’s journal Clinical Cancer Research and ASCO’s Journal of Clinical Oncology.

October 17, 2022

In conjunction with the World Cancer Congress, the American Society of Clinical Oncology, Inc. (ASCO®) is publishing a special series of its online publication JCO Global Oncology focused on innovative, evidence-based models for cancer professionals and patients to improve access to quality cancer care particularly in low- and middle-income countries (LMICs). During Congress sessions, leaders from ASCO will explore integrating palliative care into standard oncology practice; increasing cancer research and clinical trials in Africa; ensuring a supply of essential medicine for all patients regardless of resource setting; and using lessons learned from the COVID-19 pandemic to boost cancer control.https://ascopubs.org/doi/full/10.1200/GO.22.00168

October 11, 2022

Alexandria, VA. – Building on its longstanding commitment to health equity, the American Society of Clinical Oncology (ASCO) is launching a multi-year pilot program to increase access to high-quality, equitable cancer care in rural Montana.

August 10, 2022

The American Society of Clinical Oncology (ASCO) applauds President Biden for his decision to appoint ASCO-Past President Monica M. Bertagnolli, MD, FACS, FASCO, as the new Director of the National Cancer Institute (NCI). An accomplished cancer surgeon and researcher with deep expertise in community-based cancer research, Dr. Bertagnolli has the knowledge, passion, and skillset to successfully lead the nation’s top federal cancer research agency and the wider U.S. cancer research enterprise. We enthusiastically endorse her selection, recognizing Dr. Bertagnolli’s distinguished leadership and experience in advancing evidence-based cancer care and research.

July 25, 2022

The American Society of Clinical Oncology (ASCO) and the Association of Community Cancer Centers (ACCC) today jointly released two resources to help research sites increase racial and ethnic equity, diversity, and inclusion (EDI) in cancer clinical trials.

June 4, 2022

In a collaboration announced on June 4, ASCO will work with the World Health Organization (WHO) to measure and improve the quality of cancer care internationally. The goal is to achieve health-related targets of the U.N. Sustainable Development Goals and WHO Global Action Plan on Non-Communicable Diseases and help cancer professionals provide the best possible care to their patients.

May 25, 2022

Alexandria, Va — In an effort to highlight cancer care inequities during the COVID-19 pandemic, the American Society of Clinical Oncology (ASCO) has launched the Interactive Map of Oncology, a data visualization tool that allows users to explore geographic distribution of systemic and socioeconomic factors that influence cancer care delivery in the United States. Users can filter data on population demographics and risk factors by location overlaid with COVID-specific data from the COVID-19 in Oncology Registry (also known as the ASCO Registry) and other authoritative sources. 

May 19, 2022

The American Society of Clinical Oncology (ASCO) and the Association of Community Cancer Centers (ACCC) today jointly released recommendations that address the lack of equity, diversity, and inclusion (EDI) in cancer clinical trials. Published in the Journal of Clinical Oncology, “Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement” details specific actions to engage the entire cancer clinical trial ecosystem in expanding the participation of underrepresented individuals in research that advances progress against cancer.

May 11, 2022

Today, JCO Oncology Practice, a journal of the American Society of Clinical Oncology (ASCO), published a special series that examines the causes of disparities in cancer care and outcomes in the U.S. Hispanic/Latinx population and offers potential solutions to increase equity among this group. "Disparities in Cancer Care and Scientific Knowledge in Hispanic/Latinx People in the United States” features 18 articles and editorials that present new data and opportunities on a wide variety of topics, including prevention and screening, genetic testing, clinical trial enrollment and participation, access to affordable health care, and workforce representation, among others. 

 

May 3, 2022

Today the American Society of Clinical Oncology (ASCO) announced six additional medical schools will participate in the second year of the Oncology Summer Internship (OSI) program, an immersive, four-week summer internship for rising second-year medical students from groups underrepresented in medicine (UIM).

April 18, 2022

The addition of tislelizumab to chemotherapy showed statistical and clinically meaningful improvement in progression-free survival (PFS) compared with chemotherapy alone in patients with recurrent/metastatic nasopharyngeal cancer. These findings will be presented during the ASCO Plenary Series session taking place April 19, 2022, at 3:00 p.m. ET. 

April 12, 2022

The American Society of Clinical Oncology (ASCO) today announced the establishment of the ASCO Center for Equity, Diversity, and Inclusion, which will advance the Society’s equity, diversity, and inclusion (EDI) goals across the organization and throughout the wider oncology community. ASCO Chief Equity, Diversity and Inclusion Officer Sybil Green will serve as the Center’s inaugural vice president with lead responsibility for guiding and organizing the organization’s far-reaching external and internal EDI efforts.
 

February 3, 2022

“This year’s World Cancer Day theme, ‘Close the Care Gap,’ speaks to the heart of what it means to achieve progress against cancer today." 

February 1, 2022

On February 1, 2022, the American Society of Clinical Oncology (ASCO) and the American Cancer Society (ACS) initiated a collaboration to ensure that people can easily find the trusted, expert-approved cancer content they need when turning to either organization for information. As an initial step, the organizations are cross-sharing select cancer prevention, screening, and survivorship resources on their patient and consumer education websites, Cancer.Net and Cancer.org.

January 14, 2022

In many areas of the United States, the healthcare system is facing critical workforce shortages. The American Society of Clinical Oncology (ASCO) encourages public health officials and healthcare facilities to follow Centers for Disease Control and Prevention (CDC) guidelines for managing healthcare personnel with SARS-CoV-2 infection or exposure to SARS-CoV-2. These guidelines allow for different levels of restrictions on staffing based on the level of shortages being experienced. However, in making these decisions, ASCO strongly encourages institutions and public health agencies to recognize the greater risk of infection and adverse outcomes that immune-suppressed individuals, including many patients with cancer, face from SARS-CoV-2 and to make decisions about staffing for the care of those individuals with thoughtful consideration of that greater risk. Unless no alternative exists, COVID-19 positive health workers, even if asymptomatic, should not be assigned to care for patients with cancer

Pages